AB146684
Methyllycaconitine citrate (MLA) (mM/ml), alpha7 Nicotinic receptor antagonist
Be the first to review this product! Submit a review
|
(1 Publication)
MW 874.92 g/mol, Purity >98%. Potent, selective antagonist at α7-containing nicotinic receptors. Achieve your results faster with highly validated, pure and trusted compounds.
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Product protocols
For this product, it's our understanding that no specific protocols are required. You can visit:
- Visit the General protocols
- Visit the Troubleshooting
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in pharmacology 13:907713 PubMed35721159
2022
α7 Nicotinic Acetylcholine Receptor May Be a Pharmacological Target for Perioperative Neurocognitive Disorders.
Applications
Unspecified application
Species
Unspecified reactive species
Penghui Wei,Wenyuan Lyu,Lin Xu,Hao Feng,Haipeng Zhou,Jianjun Li
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com